Pfizer Faces Class Action Suit Alleging Off-Label Promotion Of Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm noted that similar lawsuits regarding marketing practices for the cholesterol-lowering drug have been dropped.